Objective-To examine the feasibility ofa national register of Down's syndrome and its effectiveness in evaluating prenatal screening for the syndrome.
Subjects-All fetuses with trisomy 21 diagnosed prenatally and live births with Down's syndrome diagnosed at birth.
Main outcome measures-Number ofprenatal and postnatal diagnoses of Down's syndrome. National and maternal age specific prevalence of Down's syndrome.
Results-For 1989 there were 1060 registrations-323 prenatal diagnoses and 737 postnatal diagnoses -after exclusion of postnatally diagnosed miscarriages and stillbirths. The estimated national rate of affected births for mothers resident in England and Wales was 1-4/1000 live births, assuming no terminations of affected pregnancies and after correction for natural losses which would have occurred in the absence of termination. The corrected maternal age specific rates were close to those found in previous population based studies. The proportion of affected pregnancies diagnosed prenatally in mothers aged 35 to 39 was 44%, and for those aged 40 or more it was 71%. Abnormal findings on ultrasonography played an unexpectedly important part in initiating cytogenetic investigation (13% of the prenatal diagnoses).
Conclusions-The findings establish the feasibility of a national Down's syndrome register and its use in evaluating prenatal screening services. Together with information held by the Office of Population Censuses and Surveys on congenital malformations, data from the register will permit studies of environmental variables affecting the prevalence of the syndrome.
Introduction
Despite advances in methods ofits prenatal diagnosis Down's syndrome is still one of the commonest severe defects found at birth. The risk increases with maternal age and prenatal services are traditionally directed at women over the age of 34, but most affected births are to women below the age of 35.
The National Down Syndrome Cytogenetic Register, established in 1989, provides information on the effectiveness ofthe prenatal diagnosis ofthis condition. The register is based on reports from the regional cytogenetic laboratories of England and Wales of all karyotypes that would result in a diagnosis of Down's syndrome. Over 95% of all Down's syndrome births and terminations are thought to have been cytogenetically confirmed, although this figure has not been validated. We examined the register's data for 1989.
Methods

DATA COLLECTION AND PROCESSING
With the help of the Association of Clinical Cytogeneticists every NHS and private cytogenetic laboratory in the country was contacted. The collaboration of referring obstetricians and paediatricians was sought through the laboratories and through wide publicity about the study. We had no refusals. Data returns were sometimes delayed or incomplete; this has improved since the year of the study.
The laboratories supply data by using a three part form, which does not include any personal identifying data. The form includes the cytogenetic result, indication for investigation, diagnostic test performed, origin of referral, maternal and paternal ages, name of hospital, date of birth or termination of the affected fetus, gestational age at testing or delivery, and town of residence and postcode. After completion most laboratories send the top copy to the register, attach the next copy to the cytogenetic report with a request to the referring clinician to supply any missing information directly (over 80% do so), and retain the last copy. Other laboratories collect the clinical information themselves and forward the complete data set at agreed intervals.
Each register entry is checked for a possible match with any earlier diagnosis, and clinical forms are linked with cytogenetic return forms. Data are coded and entered into the microcomputer by using the statistical package for the social sciences (SSPS PC). Six monthly lists of records are returned to the laboratories for a check on details and completeness.
Records of Down's syndrome registered births for each calendar year are compared with anonymous data collected through the voluntary notification of congenital malformations to the Office of Population Censuses and Surveys (form SD56).' By using the date of birth, sex, and birthplace of each child, and, when available, the date of birth or age of the mother, it is usually possible to match the two records, and this acts as validation for both data sets.
EXCLUSIONS
Babies with Down's syndrome born to mothers resident outside the regions of England and Walesfor example, in the Channel Isles and the Isle of Manor births overseas to service families were excluded, as were stillbirths or miscarriages that were diagnosed postnatally.
CASES
In 1989, 1060 diagnoses of Down's syndrome were registered (table I). These were categorised by time of diagnosis and outcome where this was known. This figure includes one stillbirth, two births, and 11 terminations diagnosed in 1989 but born or terminated early in 1990, but does not include affected pregnancies diagnosed in 1988 but terminated in 1989.
DATA ANALYSIS
Only simple cross tabulation of data was performed. Calculations of the maternal age specific pregnancy and BMJ VOLUME 303birth rates were complicated by lack ofknown maternal age in 7% of cases (although some of this information came in after this report was prepared). For the calculation of rates we assumed that cases for which maternal age was unknown were distributed in proportion to those of known age.
To calculate the rate of Down's syndrome births assuming no intervention the number of cases in which Down's syndrome was diagnosed prenatally was adjusted to allow for natural pregnancy wastage. Thus the number of cases reported after chorionic villus sampling was multiplied by 056 to allow for a prenatal loss rate of 44%. This figure is obtained by combining an additional 21% rate of loss between chorionic villus sampling and amniocentesis found by Hook et a! with the 23% rate of loss between amniocentesis and birth. 3 The overall rate of loss in the cases in which chorionic villus sampling was not performed, including those detected by ultrasonography (sometimes followed by fetal blood sampling), was assumed to be 23% and a factor of 0-77 was used to calculate the expected incidence at birth for these pregnancies (see table II There were pronounced regional differences in the proportion of cases diagnosed prenatally, ranging from 19% to 36%, but interpretation of these differences must await the planned collection of complete data on maternal age and be related to the regional distribution of maternal ages.
INDICATIONS GIVEN FOR KARYOTYPING
Prenatal diagnosis had been carried out in 323 cases and maternal age was known in 318. In 78% of these the indication for karyotyping had been maternal age, in 12-7% an abnormal ultrasound scan, in 4-6% a low maternal serum cc fetoprotein level, in 2-8% a family history of Down's syndrome, and in 0-6% a positive triple test result' (other reasons 1-3%). That karyotyping took place in 40 cases because of diagnostic ultrasonography was an unexpected finding.
Discussion
Our results show the feasibility and usefulness of a register of Down's syndrome. Agreement with other reports of age specific rates (after correcting for the proportion of terminated pregnancies which would have been lost naturally) suggests that virtually all viable cases are being registered. Further comparisons with cases known to district health authorities showed that only a small number of cases are diagnosed on clinical grounds alone without confirmatory cytogenetic test results.
The enhancement of Office of Population Censuses and Surveys data by requesting from district health authorities retrospective notifications of apparently missing cases will make possible the national studies of possible environmental effects on the risk of Down's syndrome recommended in the Black report.9 Office of Population Censuses and Surveys data, although anonymous, includes residential postcodes and, for a proportion of cases, parental occupations. It is to be hoped that information derived from the new form for notifications of legal termination of pregnancy'O will correspond more closely to the cytogenetic register, for it is important that good data on the rates of Down's syndrome births and termination of affected pregnancies are available for health care planning.
The major findings of this provisional report relate to the high proportion of prenatal diagnoses (30 5% observed, 24 3% after correction for natural fetal loss). This contrasts with the estimated 14% reported for 1974_7.h The increase may reflect more efficient screening, including the increased use of ultrasound examination in the mid-trimester. Useful data on the different proportions of affected fetuses terminated in different maternal age groups are accumulating, the quality ofwhich will be improved when information on maternal age is complete. From these data it seems that 44% of affected pregnancies in mothers aged 35-39 are terminated, and 71% in those aged 40 or more. There is no information on the proportion of women who were offered prenatal diagnosis and declined; this question needs to be asked at a confidential inquiry level.
Lastly, the data showed an unexpectedly high proportion of cases of prenatal diagnoses in which the indication for cytogenetic investigation was an abnormal result on ultrasound examination (12 7%); five fetuses in this category were reported as having a cystic hygroma. An important function of this register, which is currently funded up to 1992, will be to observe changes in the proportion of affected pregnancies first suspected after specific or non-specific findings on ultrasonography and to monitor any increase in the number of cases first detected by improved maternal serum screening.
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